Brief: Dynavax Technologies Q3 EPS USD 0.13
07/11/2024 21:02
Nov 07 (Reuters) - Dynavax Technologies Q3 operating expenses USD 70.548 million. * Q3 operating income USD 10.082 million * Q3 net income USD 17.594 million * Q3 pretax profit USD 19.818 million
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality